Related Experiment Videos
Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease
O Blin1, A M Ferrandez, J Pailhous
1Clinique des maladies du système nerveux et de l'appareil locomoteur, CHU Timone, Marseille, France.
Journal of the Neurological Sciences
|May 1, 1991
Summary
Levodopa (L-Dopa) treatment improved energy-related gait parameters in Parkinson's disease patients, but rhythm-related parameters remained resistant. This suggests complex mechanisms beyond dopamine deficiency contribute to gait disorders.
Area of Science:
- Neuroscience
- Biomechanical Engineering
- Movement Disorders
Background:
- Parkinson's disease (PD) is characterized by progressive motor deficits, including significant gait disturbances.
- Gait impairments in PD are often linked to dopaminergic pathway dysfunction, but the precise mechanisms are not fully elucidated.
- Levodopa (L-Dopa) is a primary treatment, yet its effects on specific gait parameters vary.
Purpose of the Study:
- To differentiate between L-Dopa-sensitive and L-Dopa-resistant kinematic and temporal gait parameters in Parkinson's disease.
- To investigate the relationship between L-Dopa administration and gait characteristics related to energy, rhythm, and posture.
- To explore underlying mechanisms contributing to gait disorder progression in PD.
Main Methods:
- Quantitative gait analysis was conducted on 20 individuals with Parkinson's disease.
- Gait parameters were assessed before and 1 hour after acute L-Dopa administration.
- Kinematic and temporal gait variables were analyzed to identify L-Dopa-responsive and non-responsive features.
Main Results:
- Stride length and energy-related kinematic parameters (swing velocity, peak velocity) demonstrated L-Dopa sensitivity.
- Temporal gait parameters (stride duration, swing duration, stride duration variability), associated with rhythm, were L-Dopa-resistant.
- L-Dopa improved forward-leaning posture, potentially explaining stride length increases, but stride length variability showed no significant improvement.
Conclusions:
- Gait disorders in Parkinson's disease involve both dopamine-sensitive and dopamine-resistant components.
- The findings support the critical role of force control in maintaining posture and suggest non-dopaminergic mechanisms in certain gait impairments.
- Understanding the differential response of gait parameters to L-Dopa is crucial for comprehending PD progression and developing targeted therapies.